Records found: 10 Page: 1 of 1
The Annual General Shareholders’ Meeting of Esaote S.p.A. approved the Financial Statements for financial year ending December 31st, 2012
The Annual General Meeting of Shareholders of Esaote S.p.A. met today in Milan under the Chairmanship of Prof. Carlo Castellano and approved Esaote S.p.A. Financial Statements for the financial year ended December 31st, 2012.
Esaote continues to invest in Preventive Healthcare and presents MyLabTMOne Vascular, the first tablet-size ultrasound system dedicated to vascular care
For many years Esaote has been investing in this challenging field and MyLabTMOne Vascular is a clear prove that prevention, diagnosis and productivity may coexist in a versatile and compact ultrasound system that also includes advanced technologies for vascular care.
Fabrizio Landi resigns as Managing Director of Esaote - Carlos Alonso new CEO
Esaote S.p.A. announced today that Fabrizio Landi has resigned as Managing Director and General Manager of Esaote S.p.A. effective January 31st 2013. Fabrizio Landi will remain a Member of the Board of Directors of the company and a shareholder of Esaote. The same Board of Directors will appoint Carlos Alonso as Managing Director and CEO of the Esaote Group.
Esaote introduces the New G-scan Brio a revolutionary MRI approach for Weight-Bearing MRI and musculoskeletal applications and the New E-MRI Brio Release 2 platform featuring innovative Speed-Up Technology
Esaote introduces the new G-Scan Brio, a revolutionary approach for Weight-Bearing MRI and musculoskeletal applications, which allows clinicians to increase diagnostic accuracy and confidence.
Esaote extends its MyLab ultrasound imaging range with two new systems for regional anaesthesia and pain management at the 31st Annual ESRA Congress 2012
Esaote extends its MyLabtm ultrasound imaging range with MyLabtmAlpha and MyLabtmSeven, two new systems for regional anaesthesia and pain management.
Esaote MyLabTMSeven and MyLabTMAlpha Ultrasound systems will be on show for the first time at EULAR 2012, the European League Against Rheumatism
Esaote will showcase the new MyLabTMSeven and MyLabTMAlpha Ultrasound systems, the two latest additions to the MyLabTM ultrasound solutions for musculoskeletal ultrasound imaging, at the EULAR 2012 congress (Berlin - June 6 - 9, 2012).
The Annual General Shareholders Meeting of Esaote S.p.A. approved the Financial Statements as at December 31st, 2011
The Annual General Shareholders Meeting of Esaote S.p.A. met today in Milan under the Chairmanship of Prof. Carlo Castellano and approved Esaote S.p.A. Financial Statements for the year ended December 31st, 2011.
NHS SOUTH-WEST CENTRE OF EXCELLENCE INVESTS IN ENTIRE NEW SUITE OF ESAOTE MOBILE ULTRASOUND UNITS
North Bristol NHS Trust has invested in eight mobile ultrasound systems from Esaote. North Bristol NHS Trust, comprising Southmead and Frenchay Hospitals, has commissioned seven mobile MyLab™25Gold systems and one MyLab™Five ultrasound system to improve front-line patient care in anaesthaesia and intensive care.
At ECR 2012 Esaote will unveil a new breakthrough in radiology dedicated to musculoskeletal ultrasound imaging and premium performance portable systems
Esaote will attend the next European Congress of Radiology, ECR (Wien March 1-5, 2012) and will unveil a new breakthrough in radiology dedicated to musculoskeletal ultrasound imaging and premium performance portable systems.
At ECR2012 Esaote will present Intelligent Positioning and Radar view, two exclusive features of Virtual Navigator -Fusion Imaging advanced solution
Esaote will attend the next European Congress of Radiology, ECR (Wien - March 1-5, 2012) and will present two exclusive features of Virtual Navigator - Fusion Imaging advanced solution.